← All Sponsors
SPONSOR

Auricula Biosciences Inc.

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Advanced or Metastatic KRAS-mutant Tumor in Pancreatic AdenocarcinomaAdvanced or Metastatic KRAS-mutant Tumor in Colorectal CancerAdvanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung CancerAdvanced Solid TumorsAdvanced or Metastatic KRAS-mutant Tumor
NCT07148128 Phase 1, Phase 2
Recruiting

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma
United States, Canada, United Kingdom View Trial →